Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France

Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners and Specialists in Endemic Areas and Outside Endemic Areas in France

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07191223

Acronym

CoMTBEV

Enrollment

100

Registered

2025-09-24

Start date

2024-02-16

Completion date

2026-02-16

Last updated

2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tick-borne Encephalitis, France

Keywords

Tick-borne encephalitis, tick bite

Brief summary

Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Be a doctoral student or in training * Practice in France * Agree to participate in the survey.

Exclusion criteria

\- Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Tick-borne meningoencephalitis knowledge score	Up to 2 years

Countries

France

Contacts

Primary ContactYves HANSMANN, MD

yves.hansmann@chru-strasbourg.fr33 3 69 55 09 78

Outcome results